BioSyent Inc. (CVE:RX – Get Free Report) insider FAX Capital Corp. sold 500,000 shares of the company’s stock in a transaction on Tuesday, July 23rd. The shares were sold at an average price of C$10.05, for a total transaction of C$5,025,000.00.
BioSyent Price Performance
RX stock opened at C$10.90 on Wednesday. The company has a quick ratio of 6.91, a current ratio of 6.13 and a debt-to-equity ratio of 3.40. The firm has a market cap of C$126.33 million, a price-to-earnings ratio of 18.17 and a beta of 0.94. The company’s fifty day simple moving average is C$10.16 and its 200 day simple moving average is C$9.29. BioSyent Inc. has a 12-month low of C$7.66 and a 12-month high of C$11.45.
BioSyent Company Profile
Featured Articles
- Five stocks we like better than BioSyent
- How to Invest in Biotech Stocks
- 3 Small Cap Stocks That Insiders Are Buying
- What is Insider Trading? What You Can Learn from Insider Trading
- Analysts Forecast Big Upside for Western Digital—Don’t Miss Out
- What Are Dividends? Buy the Best Dividend Stocks
- 3 Must-Own Stocks for Bullish Investors in Today’s Market
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.